Management

Sequoia’s team possesses depth of experience in managing successful scientific and business operations.

The versatile R&D team is anchored by a multidisciplinary core of scientists consisting of chemists, biochemists, structural biologists, molecular biologists, and virologists familiar with the novel technologies and ideas on which Sequoia was founded.

Steve Skolsky: Muz Mansuri, Ph.D.
John W. Erickson, Ph.D.: John W. Erickson, Ph.D.
Gary G. Altman, Ph.D.: Gary G. Altman, Ph.D.
Brian Wynne, MD.: Brian Wynne, MD.
Raymond Dagger Ph.D.: Raymond Dagger Ph.D.
Michael Eissenstat, Ph.D.: Michael Eissenstat, Ph.D.
Sergei V. Gulnik, Ph.D.: Sergei V. Gulnik, Ph.D.
Robert Guttendorf, Ph.D.: Robert Guttendorf, Ph.D.
Abelardo M. Silva, Ph.D.: Abelardo M. Silva, Ph.D.
Elena Afonina, Ph.D.: Elena Afonina, Ph.D.
Douglas Ludtke, D.Sc.: Douglas Ludtke, D.Sc.

Gary G. Altman, Ph.D.

Chief Operating Officer and a co-founder of Sequoia, Altman has experiences as CEO and CSO. In 1999, he founded Hygeia, a biotech company, and licensed IP to TiboTec for a drug that is now JNJ’s Prezista® (darunavir), . That business transaction generated the funds to start Sequoia. Earlier, he left a position as CSO with a unit of Sara Lee Corporation, to become CEO of an industrial chemical company. In 1991 he became CEO of a financial services company which he ran for 12 years. During the period 1993-1998, he was a frequent guest on CNN’s Business News and Your Money. Altman teaches in the MBA program at Johns Hopkins, a member of the Economic Club of Washington, and an Ironman triathlete.